Compare TELA & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | SACH |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | 27 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 38.4M |
| IPO Year | 2019 | N/A |
| Metric | TELA | SACH |
|---|---|---|
| Price | $0.70 | $0.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.00 | $2.00 |
| AVG Volume (30 Days) | 37.7K | ★ 122.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | ★ 37.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,275,000.00 | N/A |
| Revenue This Year | $10.23 | $145.00 |
| Revenue Next Year | $14.26 | $6.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $0.77 |
| 52 Week High | $2.14 | $1.45 |
| Indicator | TELA | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 39.96 |
| Support Level | $0.67 | N/A |
| Resistance Level | $0.95 | $1.12 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 25.36 | 51.87 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.